Filing Details
- Accession Number:
- 0001127602-12-030872
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-11-15 11:37:52
- Reporting Period:
- 2012-11-13
- Filing Date:
- 2012-11-15
- Accepted Time:
- 2012-11-15 11:37:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1014739 | Bioscrip Inc. | BIOS | Retail-Drug Stores And Proprietary Stores (5912) | 050489664 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1193146 | A Stuart Samuels | 100 Clearbrook Road Elmsford NY 10523 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $.0001 Par Value | Acquisiton | 2012-11-13 | 11,200 | $4.43 | 57,700 | No | 4 | M | Direct | |
Common Stock, $.0001 Par Value | Disposition | 2012-11-13 | 11,200 | $9.66 | 46,500 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock, $.0001 Par Value | Director Stock Option | Disposition | 2012-11-13 | 11,200 | $0.00 | 11,200 | $4.43 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2012-11-20 | No | 4 | M | Direct |
Footnotes
- These sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2012.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $9.5400 to $9.7400, inclusive. The reporting person undertakes to provide BioScrip, Inc., any security holder of BioScrip, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- Fully Vested